Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Integrated Biopharma Inc (INBP)

Integrated Biopharma Inc (INBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Integrated BioPharma Reports Results for Its Quarter Ended December 31, 2025 ACCESS Newswire - Wed Feb 11, 10:30AM CST

HILLSIDE, NJ / ACCESS Newswire / February 11, 2026 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2025.

INBP : 0.3002 (-0.27%)
Integrated BioPharma Reports Results for Its Quarter Ended September 30, 2025 ACCESS Newswire - Mon Nov 10, 2025

HILLSIDE, NJ / ACCESS Newswire / November 10, 2025 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2025.

INBP : 0.3002 (-0.27%)
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2025 ACCESS Newswire - Tue Sep 23, 2025

HILLSIDE, NJ / ACCESS Newswire / September 23, 2025 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2025....

INBP : 0.3002 (-0.27%)
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2025 ACCESS Newswire - Wed May 14, 2025

HILLSIDE, NJ / ACCESS Newswire / May 14, 2025 / Integrated BioPharma, Inc. ((OTCQX:INBP)) (the "Company" or "INBP") reports its financial results for the quarter ended March 31, 2025.

INBP : 0.3002 (-0.27%)
Integrated BioPharma Reports Results for its Quarter Ended December 31, 2024 ACCESS Newswire - Thu Feb 13, 2025

HILLSIDE, NJ / ACCESS Newswire / February 13, 2025 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2024.

INBP : 0.3002 (-0.27%)
Integrated BioPharma Reports Results for its Quarter Ended December 31, 2024 ACCESS Newswire - Thu Feb 13, 2025

HILLSIDE, NJ / ACCESS Newswire / February 13, 2025 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2024.

INBP : 0.3002 (-0.27%)
Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024 ACCESS Newswire - Fri Sep 20, 2024

HILLSIDE, NJ / ACCESSWIRE / September 20, 2024 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2024.

INBP : 0.3002 (-0.27%)
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2024 ACCESS Newswire - Fri Sep 20, 2024

HILLSIDE, NJ / ACCESSWIRE / September 20, 2024 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2024.

INBP : 0.3002 (-0.27%)
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2024 ACCESS Newswire - Fri May 10, 2024

HILLSIDE, NJ / ACCESSWIRE / May 10, 2024 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended March 31, 2024.

INBP : 0.3002 (-0.27%)
Integrated BioPharma Reports Results for its Quarter Ended September 30, 2023 ACCESS Newswire - Thu Nov 9, 2023

HILLSIDE, NJ / ACCESSWIRE / November 9, 2023 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2023.

INBP : 0.3002 (-0.27%)

Barchart Exclusives

As Dell Technologies Raises Its Dividend 20%, Should You Buy DELL Stock? Barchart - Tue Mar 10, 6:30PM CDT
With a 20% dividend hike, is Dell Technologies giving investors another reason to consider picking up its shares now? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot